| Literature DB >> 31755946 |
Dennis T Ko1,2,3, Anna Chu1, Peter C Austin1, Sharon Johnston4,5, Brahmajee K Nallamothu6, Idan Roifman1,2,3, Natasa Tusevljak1, Jacob A Udell1,3,7, Erica Frank8.
Abstract
Importance: Although cardiovascular disease is the leading cause of death in most developed countries, little is known about current physicians' cardiovascular health and outcomes. Objective: To compare cardiac risk factor burden, health services use, and major cardiovascular event incidence between physicians and the general population. Design, Setting, and Participants: This cohort study used data from practicing physicians and nonphysicians without cardiovascular disease aged 40 to 75 years in Ontario, Canada. Cohorts were assembled beginning January 1, 2008, and were followed up to December 31, 2015. Data analysis was performed between November 2017 and September 2019. Exposure: Being a practicing physician. Main Outcomes and Measures: The primary outcome was 8-year incidence of a major cardiovascular event (ie, cardiovascular death or hospitalization for myocardial infarction, stroke, heart failure, or coronary revascularization). Secondary outcomes included health services used, such as physician assessments and guideline-recommended tests.Entities:
Year: 2019 PMID: 31755946 PMCID: PMC6902820 DOI: 10.1001/jamanetworkopen.2019.15983
Source DB: PubMed Journal: JAMA Netw Open ISSN: 2574-3805
Figure. Cohort Creation
Flowchart shows exclusion criteria for the Cardiovascular Health in Ambulatory Care Health Research Team (CANHEART) cohort.
Demographic and Baseline Characteristics of Physicians and the General Population
| Variable | No. (%) | ||
|---|---|---|---|
| Physicians (n = 17 071) | General Population (n = 5 306 038) | ||
| Demographic characteristics | |||
| Age on January 1, 2008, mean (SD), y | 53.3 (8.8) | 53.7 (9.5) | <.001 |
| Male | 11 963 (70.1) | 2 556 044 (48.2) | <.001 |
| Highest neighborhood income quintile | 10 380 (61.0) | 1 137 565 (21.5) | <.001 |
| Rural residence | 1132 (6.6) | 673 276 (12.7) | <.001 |
| Immigrant status | |||
| Long-term resident | 15 893 (93.1) | 4 542 423 (85.6) | <.001 |
| Immigrated to Canada, y | |||
| 10-20 | 674 (3.9) | 435 168 (8.2) | |
| <10 | 504 (3.0) | 328 447 (6.2) | |
| Ethnicity | |||
| Non-Chinese and non–South Asian | 15 306 (89.7) | 4 898 898 (92.3) | <.001 |
| Chinese | 1078 (6.3) | 263 540 (5.0) | |
| South Asian | 687 (4.0) | 143 600 (2.7) | |
| Cardiac risk factors | |||
| Hypertension | 2887 (16.9) | 1 568 382 (29.6) | <.001 |
| Diabetes | 855 (5.0) | 599 548 (11.3) | <.001 |
| Smoker | 1708 (13.1) | 1 075 275 (21.6) | .03 |
| Cholesterol levels, mg/dL | |||
| Total cholesterol | |||
| Mean (SD) | 197.3 (38.7) | 202.6 (40.2) | <.001 |
| >240 mg/dL | 451 (13.3) | 219 004 (16.5) | <.001 |
| Low-density lipoprotein cholesterol | |||
| Mean (SD) | 115.9 (34.0) | 119.5 (34.8) | <.001 |
| >130 mg/dL | 1082 (33.2) | 465 594 (36.8) | <.001 |
| High-density lipoprotein cholesterol, mg/dL, mean (SD) | 58.7 (16.6) | 56.7 (16.2) | <.001 |
| Comorbidities | |||
| Atrial fibrillation | 304 (1.8) | 59 193 (1.1) | <.001 |
| Cancer | 824 (4.8) | 249 699 (4.7) | .46 |
| Chronic obstructive pulmonary disease | 293 (1.7) | 417 470 (7.9) | <.001 |
| Asthma | 797 (4.7) | 539 040 (10.2) | <.001 |
| Johns Hopkins ACG score, mean (SD) | 6.0 (4.0) | 8.0 (4.4) | <.001 |
Abbreviation: ACG, Adjusted Clinical Groups.
SI conversion factors: to convert total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol to mmol/L, multiply by 0.0259.
Data are from a subpopulation of respondents to the 2001 to 2012 Canadian Community Health Surveys (185 physicians and 94 802 members of the general population). Information on smoking was available for 1.8% of individuals who completed the Canadian Community Health Survey.
Data are from a subpopulation of individuals with test results from Dynacare Medical Laboratories between 2002 and 2007 (3395 physicians and 1 326 939 members of the general population). Where multiple cholesterol values were available, we used the result closest to January 1, 2008. Fasting cholesterol values were recommended at the time of the study. Information on lipid results was available for 25.0% of the study population who completed cholesterol testing.
The Johns Hopkins ACG score is a measure of comorbidity based on a patient’s age, sex, and diagnosis codes from ambulatory and in-patient care settings in the previous 5 years, and was determined using The Johns Hopkins ACG System Version 7. The range of possible scores is 0 to 32, with lower scores indicating fewer comorbid conditions.
Use of Health Services Among Physicians and the General Population
| Variable | Use Rate, % (95% CI) | ||
|---|---|---|---|
| Physicians (n = 17 071) | General Population (n = 5 306 038) | ||
| Physician visits | |||
| Primary care physician | 88.1 (86.4-89.9) | 93.6 (93.5-93.7) | <.001 |
| Annual visits, mean, No. (95% CI) | 1.7 (1.7-1.8) | 4.0 (4.0-4.0) | <.001 |
| Any specialist | 93.6 (91.8-95.4) | 85.4 (85.3-85.5) | <.001 |
| Annual visits, mean, No. (95% CI) | 3.0 (2.9-3.1) | 2.2 (2.2-2.2) | <.001 |
| Cardiologist | 25.2 (24.2-26.3) | 19.5 (19.4-19.5) | <.001 |
| Periodic health examination | 58.9 (57.5-60.4) | 67.9 (67.8-67.9) | <.001 |
| Cardiac risk factor assessment | |||
| Screening | |||
| Cholesterol | 76.3 (74.7-78.0) | 83.8 (83.7-83.9) | <.001 |
| Diabetes | 79.0 (77.3-80.8) | 85.3 (85.2-85.4) | <.001 |
| Cardiac testing | |||
| Electrocardiography | 64.4 (62.9-65.9) | 72.4 (72.3-72.5) | <.001 |
| Echocardiography | 34.0 (32.8-35.2) | 32.3 (32.2-32.3) | .004 |
| Noninvasive stress test | 29.1 (28.0-30.1) | 29.7 (29.6-29.7) | .26 |
Rates were age- and sex-standardized to the 2006 Ontario Census population.
Cholesterol screening was calculated among all individuals aged 40 years or older, as recommended by the Canadian Cardiovascular Society. Diabetes screening was calculated among all nondiabetic individuals at baseline and excluded testing during pregnancy.
Adjusted HRs of Cardiovascular Outcomes Comparing Physicians and the General Population
| Outcomes | Incidence per 1000 Person-Years (No. of Events) | HR (95% CI) | |
|---|---|---|---|
| Physicians | General Population | ||
| Cardiovascular death, myocardial infarction, stroke, heart failure, or coronary revascularization | 4.4 (602) | 7.1 (249 666) | 0.78 (0.72-0.85) |
| Cardiovascular death | 0.7 (64) | 1.5 (50 704) | 0.45 (0.35-0.58) |
| Myocardial infarction, stroke, or heart failure | 2.2 (300) | 4.3 (153 900) | 0.66 (0.59-0.74) |
| Myocardial infarction | 1.2 (181) | 2.2 (83 169) | 0.68 (0.58-0.78) |
| Stroke | 0.8 (97) | 1.4 (48 245) | 0.73 (0.60-0.89) |
| Coronary revascularization | 2.7 (422) | 3.6 (130 727) | 0.94 (0.86-1.04) |
Abbreviation: HR, hazard ratio.
Incidence rates are age- and sex-standardized to the 2006 Ontario census population. Hazard ratios are adjusted for demographic characteristics (age and sex), socioeconomic status (as measured by neighborhood income quintile), cardiac risk factors (smoking, hypertension, diabetes, and cholesterol levels), comorbidity score, and use of health services (physician assessments). General population was the reference group.
Factors Associated With Cardiovascular Outcomes in Physicians and the General Population
| Factor | Physicians | General Population | ||
|---|---|---|---|---|
| HR (95% CI) | HR (95% CI) | |||
| Participants, No. | 17 071 | 5 306 038 | ||
| Demographic characteristics | ||||
| Age on January 1, 2008, per y | 1.07 (1.06-1.08) | <.001 | 1.06 (1.06-1.07) | <.001 |
| Female | 0.35 (0.26-0.47) | <.001 | 0.46 (0.45-0.46) | <.001 |
| Income quintile | ||||
| 1 | 0.94 (0.68-1.28) | .68 | 1.32 (1.30-1.33) | <.001 |
| 2 | 0.97 (0.79-1.36) | .88 | 1.19 (1.17-1.20) | <.001 |
| 3 | 1.03 (0.79-1.35) | .81 | 1.14 (1.12-1.15) | <.001 |
| 4 | 0.95 (0.76-1.20) | .68 | 1.08 (1.07-1.10) | <.001 |
| Cardiac risk factors | ||||
| Hypertension | 1.28 (1.05-1.55) | .01 | 1.50 (1.48-1.51) | <.001 |
| Diabetes | 1.56 (1.20-2.03) | <.001 | 1.67 (1.66-1.69) | <.001 |
| Smoker | 1.15 (0.85-1.55) | .38 | 1.50 (1.48-1.53) | <.001 |
| Cholesterol (per mmol/L) | ||||
| Total | 1.06 (0.96-1.18) | .27 | 1.07 (1.06-1.07) | <.001 |
| High-density lipoprotein | 0.73 (0.58-0.93) | .01 | 0.75 (0.74-0.76) | <.001 |
| Johns Hopkins ACG score | 1.00 (0.97-1.03) | .96 | 1.02 (1.01-1.02) | <.001 |
Abbreviations: ACG, Adjusted Clinical Groups; HR, hazard ratio.
The fifth quintile is the highest income level and is the reference against which the other levels are compared (HR = 1; not shown).
The Johns Hopkins ACG score is a measure of comorbidity based on a patient’s age, sex, and diagnosis codes from ambulatory and in-patient care settings in the previous 5 years, and was determined using The Johns Hopkins ACG System Version 7. The range of possible scores is 0 to 32, with lower scores indicating fewer comorbid conditions.